by Emily Sparrow | Oct 16, 2015
According to RAPS.org, the Trans-Pacific Partnership (TPP) recently came to a compromise that would “provide eight years of exclusivity to biologic drugs, or provide five years of exclusivity, plus up to three more years under a regulatory framework for the 12...
by Emily Sparrow | Oct 16, 2015
In an In-Pharma article by Dan Stanton, Robert Fish discusses how to avoid 483 observations during audits. Fish, who served as FDA inspector for over 30 years, stressed the importance of knowing application details and training employees through mock inspections. In...
by Emily Sparrow | Oct 16, 2015
The Pentagon recently contributed $75 million to an initiative called “Flexible Hybrid Electronics Manufacturing Innovation Hub” in Silicon Valley. According to PARC, the market for flexible electronics is growing exponentially and is expected to reach $45 billion...
by Emily Sparrow | Oct 16, 2015
In-Pharma is interested in finding out which mobile operating system is the most preferred among the drug industry between Andriod and iOS. Take this survey to help Gareth MacDonald conduct the necessary research.
by Emily Sparrow | Oct 16, 2015
On October 29, the Indiana Medical Device Manufacturers Council (IMDMC) is hosting their annual conference. Governor Mike Pence will be attending as the keynote speaker. There is still time to register for a booth or sponsorship. Make sure to stop by Pearl Pathways’...
